Search Results

Lutronic Vision (“Lutronic” or the “Company”), a wholly-owned subsidiary of Lutronic Corporation, today announced that it has treated the first early-stage Age-Related Macular Degeneration (“AMD”) patient in its clinical trial evaluating the R:GENTM laser.

Lutronic, the global leader in the development and manufacture of innovative laser technology for aesthetic and ophthalmic medicine, powerfully affirms its commitment to its aesthetic customers with a comprehensive program combining customer and employee safety with exceptional client support.

Lutronic, a global leader in creating intelligent, energy-based systems for medical aesthetics, has unveiled Accufit, their exceptional new device for targeted muscle activation. Accufit takes muscle activation to strengthen and sculpt muscle in the abdomen, obliques, and buttocks - to new levels with innovative technology. In ef

Candela and MGH Grant License; Comprehensive Settlement Reached

Cutera, Inc., a leading provider of aesthetic and dermatology solutions, reported financial results for the first quarter ended March 31, 2024.

The global aesthetic medicine market reached a valuation of US$ 75.6 billion in 2023.